Delivery Order SPE2DB22D2007-SPE2DB25FJ2KR
- Not listed
- The Defense Logistics Agency's Medical Supply Chain awarded a $10,639.28 delivery order to AmerisourceBergen Drug Corp on July 25, 2025, for Sandostatin LAR Depot 20 mg kits, with performance completion targeted for July 28, 2025. This competitively awarded, firm fixed-price delivery order carries no set-aside designation and will be fulfilled at AmerisourceBergen's corporate office location in Conshohocken, Pennsylvania. The contract represents a child order under AmerisourceBergen's larger...
- The Defense Logistics Agency awarded a delivery order to AmerisourceBergen Drug Corp for Sandostatin LAR Depot 10 mg kits valued at $2,844.34 with a firm fixed price structure. The award, issued on October 17, 2025, represents a non-competitive delivery order without set-aside designation, with an ultimate completion date of October 20, 2025. AmerisourceBergen will perform this work from its corporate office location in Conshohocken, Pennsylvania, where the company maintains its headquarters...
- The Defense Logistics Agency awarded a delivery order valued at $19,336.91 to AmerisourceBergen Drug Corp for Sandostatin LAR Depot 30 mg kits under a firm fixed price contract. This non-competitive delivery order was executed on August 4, 2025, with an ultimate completion date of August 5, 2025. AmerisourceBergen Drug Corp, a major pharmaceutical distributor headquartered in Conshohocken, Pennsylvania, fulfilled the delivery requirement from its corporate office location in the same city....
- The Defense Logistics Agency awarded a $8,146.73 firm fixed-price delivery order to AmerisourceBergen Drug Corp for Sandostatin LAR Depot 30 mg kits, with an ultimate completion date of August 22, 2025. This non-set-aside award represents a competitive procurement executed on August 21, 2025, with performance based in Conshohocken, Pennsylvania. The delivery order falls under AmerisourceBergen's larger Indefinite Delivery Contract (IDC) with DLA Troop Support Medical, valued at $999,999,999.00...
- The Defense Logistics Agency awarded a $12,832.80 delivery order to AmerisourceBergen Drug Corp on September 16, 2025, for the supply of Sandostatin LAR Depot 30 mg kits. Scheduled for completion by September 17, 2025, this firm fixed-price delivery order represents a child contract under AmerisourceBergen's larger pharmaceutical supply vehicle with DLA. The award was made through open competition with no set-aside designation. AmerisourceBergen, headquartered in Conshohocken, Pennsylvania,...
- The Defense Logistics Agency awarded a delivery order valued at $92,418.76 to AmerisourceBergen Drug Corp for the supply of Sandostatin LAR Depot 20 mg kits. This firm fixed-price, competitively awarded delivery order was issued on September 15, 2025, with an ultimate completion date of September 16, 2025, and will be performed at AmerisourceBergen's corporate office location in Conshohocken, Pennsylvania. The contract represents a child order under AmerisourceBergen's larger Indefinite Delivery...
- The Defense Logistics Agency awarded AmerisourceBergen Drug Corp a delivery order valued at $15,958.92 for Sandostatin LAR Depot 20 mg kits on September 4, 2025, with an ultimate completion date of September 5, 2025. This is a firm fixed price contract with no set-aside designation, representing a competitively awarded delivery order under the company's existing indefinite delivery contract with DLA Troop Support Medical. The place of performance is AmerisourceBergen's corporate office...
- The Defense Logistics Agency awarded a $20,091.40 delivery order to AmerisourceBergen Drug Corp for Sandostatin LAR Depot 30 mg kits, with an ultimate completion date of August 4, 2025. This firm fixed price contract, awarded on August 1, 2025, represents a non-competitive delivery order under AmerisourceBergen's existing Indefinite Delivery Contract with DLA Troop Support Medical. The product will be performed at AmerisourceBergen's corporate office location in Conshohocken, Pennsylvania....
- The Defense Logistics Agency awarded a delivery order to AmerisourceBergen Drug Corp for $10,639.28 on September 19, 2025, for the supply of Sandostatin LAR Depot 20 mg kits, with an ultimate completion date of September 22, 2025. This competitively awarded, firm fixed-price contract contains no set-aside designation and will be performed at the company's Corporate Office location in Conshohocken, Pennsylvania. AmerisourceBergen Drug Corp, a major pharmaceutical distributor and critical...
- The Defense Logistics Agency awarded a delivery order valued at $20,024.51 to AmerisourceBergen Drug Corp for the supply of Sandostatin LAR Depot 30 mg kits under a firm fixed price contract. The award, issued on August 18, 2025, represents a competitively awarded, non-set-aside procurement with an ultimate completion date of August 19, 2025. The product will be delivered to the place of performance in Conshohocken, Pennsylvania, where AmerisourceBergen maintains its corporate headquarters. This...
- SPE2DB22D2007Indefinite Delivery Contract
- SPE2DB22D2007-SPE2DB25FJ2KRDelivery Order
The Defense Logistics Agency awarded a $22,084.22 delivery order to AmerisourceBergen Drug Corp on June 18, 2025, for the supply of Sandostatin LAR Depot 20 mg kits. The contract is structured as a firm fixed-price delivery order with an ultimate completion date of June 20, 2025, and represents a non-set-aside competitive award. AmerisourceBergen Drug Corp, a major pharmaceutical distributor headquartered in Conshohocken, Pennsylvania, will perform the work at its corporate office location in Conshohocken, PA. This delivery order falls under AmerisourceBergen's larger Indefinite Delivery Contract (IDC) with DLA Troop Support Medical, valued at $999,999,999.00 and extending through December 2026. The prime IDC serves as a comprehensive global pharmaceutical support vehicle enabling the company to supply a wide range of medications, vaccines, medical devices, and specialized healthcare commodities to support military healthcare programs worldwide. The delivery order for Sandostatin LAR Depot—an octreotide-based medication used in treating acromegaly and neuroendocrine tumors—exemplifies the type of specialty pharmaceutical products the company furnishes through this strategic contract vehicle to support Defense Health Agency operations and other federal healthcare systems.
Mod # | Description | ReasonForModification | Federal Obligation | Date |
|---|---|---|---|---|
| Not listed | Not listed | $22.1k | 6/18/25 |